Neil Cashman

Neil Cashman

Company: ProMIS Neurosciences

Job title: CSO & Co-Founder


Dr. Neil Cashman is CSO of ProMIS Neurosciences, and Professor of Neurology at the University of British Columbia. His industrial-academic translational research program is focused on the pathogenesis and treatment of protein misfolding diseases, including Alzheimer’s and Parkinson’s disease, and amyotrophic lateral sclerosis (ALS).  


Panel Discussion: Conducting a Strategic Analysis of Protein Misfolding Therapeutics 2:00 pm

• What are the strengths of companies active in developing protein misfolding therapeutics? • What is a bird’s eye view of the space in terms of how money has flowed in/out? • What do companies in this space need to change or improve to accelerate their scientific progress? • What is the market opportunity and…Read more

day: Day Two

Precision Immunotherapies for Protein Misfolding Diseases: The ProMIS Platform 11:30 am

• Toxic, propagating misfolded proteins underlie neurodegeneration • Antibodies directed against protein misfolding-selective epitopes can neutralize toxicity and propagation in diseaseRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.